FAQ/Help |
Calendar |
Search |
Today's Posts |
08-13-2010, 10:31 AM | #1 | |||
|
||||
Senior Member
|
http://www.nytimes.com/2010/08/13/he...imer.html?_r=1
Rare Sharing of Data Leads to Progress on Alzheimer’s By GINA KOLATA In 2003, a group of scientists and executives from the National Institutes of Health, the Food and Drug Administration, the drug and medical-imaging industries, universities and nonprofit groups joined in a project that experts say had no precedent: a collaborative effort to find the biological markers that show the progression of Alzheimer’s disease in the human brain. Now, the effort is bearing fruit with a wealth of recent scientific papers on the early diagnosis of Alzheimer’s using methods like PET scans and tests of spinal fluid. More than 100 studies are under way to test drugs that might slow or stop the disease. And the collaboration is already serving as a model for similar efforts against Parkinson’s disease. A $40 million project to look for biomarkers for Parkinson’s, sponsored by the Michael J. Fox Foundation, plans to enroll 600 study subjects in the United States and Europe. The work on Alzheimer’s “is the precedent,” said Holly Barkhymer, a spokeswoman for the foundation. “We’re really excited.” The key to the Alzheimer’s project was an agreement as ambitious as its goal: not just to raise money, not just to do research on a vast scale, but also to share all the data, making every single finding public immediately, available to anyone with a computer anywhere in the world. No one would own the data. No one could submit patent applications, though private companies would ultimately profit from any drugs or imaging tests developed as a result of the effort.
__________________
Carey “Cautious, careful people, always casting about to preserve their reputation and social standing, never can bring about a reform. Those who are really in earnest must be willing to be anything or nothing in the world’s estimation, and publicly and privately, in season and out, avow their sympathy with despised and persecuted ideas and their advocates, and bear the consequences.” — Susan B. Anthony |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Safra helps fund MJFF Biomarkers Study - Wall Street Journal | Parkinson's Disease | |||
MJFF Upcoming Biomarkers Study | Parkinson's Disease | |||
USA / Parkinson's Biomarker Study- NINDS | Parkinson's Disease | |||
MJFF CEO Katie Hood in Huffington Post today | Parkinson's Disease | |||
Interesting article in the NY times today on gluten-free dining-- | Gluten Sensitivity / Celiac Disease |